Angiotensin-converting enzyme (ACE) inhibitors modulate cellular retinol-binding protein 1 and adiponectin expression in adipocytes via the ACE-dependent signaling cascade

Molecular Pharmacology

Volumn 75, Issue 3, 2009, Pages 685-692

  Kohlstedt, Karin ^a   Gershome, Cynthia ^a   Trouvain, Caroline ^a   Hofmann, Wolf Karsten ^b   Fichtlscherer, Stephan ^a   Fleming, Ingrid ^a  

^a GOETHE UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CELLULAR RETINOL BINDING PROTEIN 1; DIPEPTIDYL CARBOXYPEPTIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RAMIPRIL; RAMIPRILAT; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; ROSIGLITAZONE; SMALL INTERFERING RNA; CELLULAR RETINOL BINDING PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA RESPONSIVE ELEMENT; DOWN REGULATION; DRUG POTENTIATION; ENDOTHELIUM CELL; ENZYME INHIBITION; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN SECRETION; UPREGULATION; WILD TYPE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL STRAIN 3T3; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, OBESE; PEPTIDYL-DIPEPTIDASE A; RETINOL-BINDING PROTEINS, CELLULAR; SIGNAL TRANSDUCTION;

EID: 62149133481     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.051631     Document Type: Article

References (36)

1. Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, Qi N, Wang J, Avery MA, and Kurtz TW (2004) Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARy-modulating activity. Hypertension 43:993-1002.
2. Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F. Probstfield J, Fodor G. and Holman RR (2006) Effect of ramipril on the incidence of diabetes. N Engl J Med 355:1551-1562.
3. Busse R and Lamontagne D (1991) Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells. Naunyn Schmiedebergs Arch Pharmacol 344:126-129.
4. Chawla A, Repa JJ, Evans RM, and Mangelsdorf DJ (2001) Nuclear receptors and lipid physiology: opening the X-files. Science 294:1866-1870.
5. Clasen R, Schupp M, Foryst-Ludwig A, Sprang C, Clemenz M, Krikov M, Thöne Reineke C, Unger T, and Kintscher U (2005) PPARy-activating angiotensin type-1 receptor blockers induce adiponectin. Hypertension 46:137-143.
6. Dagenais GR, Pogue J, Fox K, Simoons ML, and Yusuf S (2006) Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet 388:581-588.
7. Engeli S, Negrel R, and Sharma AM (2000) Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 35:1270-1277.
8. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, and Giugliano D (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. J Am Med Assoc 289:1799-1804.
9. Esteller M, Guo M, Moreno V, Peinado MA, Capella G, Galm O, Baylin SB, and Herman JG (2002) Hypermethylation-associated inactivation of the cellular retinol-binding-protein 1 gene in human cancer. Cancer Res 62:5902-5905.
10. Farias EF, Marzan C, and Mira-y-Lopez R (2005a) Cellular retinol-binding protein-Iinhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates P85-P110 heterodimerization. Oncogene 24:1598-1606.
11. Farias EF, Ong DE, Ghyselinck NB, Nakajo S, Kuppumbatti YS, and Mira y Lopez R (2005b) Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity. J Natl Cancer Inst 97:21-29.
12. Ferchak CV and Meneghini LF (2004) Obesity, bariatric surgery and Type 2 diabetes-a systematic review. Diabetes Metab Res Rev 20:438-445.
13. Fleming I (2006) Signaling by the angiotensin-converting enzyme. Circ Res 98:887-896.
14. Furuhashi M, Ura N, Higashiura K, Murakami H, Tanaka M, Moniwa N, Yoshida D, and Shimamoto K (2003) Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 42M:76-81.
15. Ghyselinck NB, Båvik C, Sapin V, Mark M, Bonnier D, Hindelang C, Dierich A, Nilsson CB, Håkansson H, Sauvant P, Azaïs-Braesco V, Frasson M, Picaud S, and Chambon P (1999) Cellular retinol-binding protein I is essential for vitamin A homeostasis. EMBO J 18:4903-4914.
16. Gillespie EL, White CM, Kardas M, Lindberg M, and Coleman CI (2005) The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care 28:2261-2266.
17. Harada H, Miki R, Masushige S, and Kato S (1995) Gene expression of retinoic acid receptors, retinoid-X receptors, and cellular retinol-binding protein I in bone and its regulation by vitamin A. Endocrinology 136:5329-5335.
18. Hermann TS, Li W, Dominguez H, Ihlemann N, Rask-Madsen C, Major-Pedersen A, Nielsen DB, Hansen KW, Hawkins M, Kober L, and Torp-Pedersen C (2006) Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes. J Clin Endocrinol Metab 91:1001-1008.
19. Hotta K, Funaliashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, and Matsuzawa Y (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vase Biol 20: 1595-1599.
20. Kohlstedt K, Brandes RP, Müller-Esterl W, Busse R, and Fleming I (2004) Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells. Circ Res 94:60-67.
21. Kohlstedt K, Gershome C, Friedrich M, Müller-Esterl W, Alhenc-Gelas F, Busse R, and Fleming I (2006) Angiotensin-converting enzyme (ACE) dimerization is the initial step in the ACE inhibitor-induced ACE signaling cascade in endothelial cells. Mol Pharmacol 69:1725-1732.
22. Kohlstedt K, Shoghi F, Müller-Esterl W, Busse R, and Fleming I (2002) CK2 phoshorylates the angiotensin-converting enzyme and regulates its retention in the endothelial cell plasma membrane. Circ Res 91:749-756.
23. Lepreux S, Bioulac-Sage P, Gabbiani G, Sapin V, Housset C, Rosenbaum J, Balabaud C, and Desmoulière A (2004) Cellular retinol-binding protein-1 expression in normal and fibrotic/cirrhotie human liver: different patterns of expression in hepatic stellate cells and (myo)fibroblast subpopulations. J Hepatol 40:774-780.
24. Lissoos TW, Davis AE, and Levin MS (1995) Vitamin A trafficking in Caco-2 cells stably transfected with cellular retinol binding proteins. Am J Physiol 268:G224-G231.
25. Lithell HO, Pollare T, and Berne C (1990) Insulin sensitivity in newly detected hypertensive patients: influence of captopril and other antihypertensive agents on insulin sensitivity and related biological parameters. J Cardiovasc Pharmacol 15 (Suppl 5):S46-S52.
26. Michalik L and Wahli W (2007) Guiding ligands to nuclear receptors. Cell 129:649 -651.
27. Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, Kataoka T, Kamimori K, Shimodozono S, Kobayashi Y, Yoshiyama M, Takeuchi K, and Yo-shikawa J (2004) Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 90:528-533.
28. Napoli JL (1999) Interactions of retinoid binding proteins and enzymes in retinoid metabolism. Biochim Biophys Acta 1440:139-162.
29. Oh DK, Ciaraldi T, and Henry RR (2007) Adiponectin in health and disease. Diabetes Obes Metab 9:282-289.
30. Oksa A, Gajdos M, Fedelesová V, Spustová V, and Dzúrik R (1994) Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension. J Cardiovasc Pharmacol 23:79-86.
31. Okuno M, Garaveo VE, Goodman DS, and Blaner WS (1995) Regulation of adipocyte gene expression by retinoic acid and hormones: effects on the gene encoding cellular retinol-binding protein. J Lipid Res 36:137-147.
32. Opie LH and Schall R (2004) Old antihypertensives and new diabetes. J Hypertens 22:1453-1458.
33. Schupp M, J alike J, Clasen R, Unger T, and Kintscher U (2004) Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 109:2054-2057.
34. Tsutsumi C. Okuno M, Tannous L. Piantedosi R, Allan M, Goodman DS, and Blaner WS (1992) Retinoids and retinoid-binding protein expression in rat adipocytes. J Biol Chem 267:1805-1810.
35. Wang HC, Ko YH, Mersmann HJ, Chen CL, and Ding ST (2006) The expression of genes related to adipocyte differentiation in pigs. J Anim Sci 84:1059-1066.
36. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, and Dagenais G (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart, outcomes prevention evaluation study investigators. N Engl J Med 342:145-153.